A detailed history of Oliver Luxxe Assets LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 84,671 shares of INVA stock, worth $1.88 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
84,671
Holding current value
$1.88 Million
% of portfolio
0.32%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$16.67 - $22.28 $1.41 Million - $1.89 Million
84,671 New
84,671 $1.88 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.55B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.